Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele

Kumar Rajan, Lisa L. Barnes, Robert S. Wilson, Jennifer Weuve, Elizabeth A. McAninch, Denis A. Evans

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objective: To examine the association of blood pressure (BP) with incident Alzheimer's disease (AD) dementia. Methods: This work is based on a longitudinal, cohort study of 18 years, the Chicago Health and Aging Project (CHAP) performed in 2,137 participants (55% black) with systolic BP measured around 8.1 years before incident AD dementia. Results: The association of BP with risk of AD dementia was U-shaped, with the lowest risks of AD dementia near the center of the systolic BP (SBP) and diastolic BP (DBP) distributions, and modestly elevated risk at lower BPs, and greater risk at higher BPs. The degree of U-shape and the range of lowest risk (threshold ranges) varied with antihypertensive medication use and presence of the APOE ε4 allele. The U-shape was most prominent for the subgroup not taking antihypertensive medications and having an APOE ε4 allele. At higher BPs, those having the APOE ε4 allele and not receiving antihypertensive medication were at greater risk of AD dementia than other groups: The risk of incident AD dementia increased by 100% (relative risk [RR] = 2.00; 95% confidence interval [CI] = 1.70, 2.31) for every 10 mm Hg increase in SBP above 140 mm Hg. For DBP, the risk of incident of AD dementia increased by 57% (RR = 1.57; 95% CI = 1.33, 1.86) for every 5 mm Hg increase in DBP above 76 mm Hg. Interpretation: The BP risk of AD dementia association is U-shaped, with elevated risk at lower and higher BPs. People having the APOE ε4 allele and not receiving antihypertensive medication with higher BPs have notably elevated risk of AD dementia. Ann Neurol 2018;83:935–944.

Original languageEnglish (US)
Pages (from-to)935-944
Number of pages10
JournalAnnals of Neurology
Volume83
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Antihypertensive Agents
Alzheimer Disease
Alleles
Blood Pressure
Confidence Intervals
Longitudinal Studies

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele. / Rajan, Kumar; Barnes, Lisa L.; Wilson, Robert S.; Weuve, Jennifer; McAninch, Elizabeth A.; Evans, Denis A.

In: Annals of Neurology, Vol. 83, No. 5, 01.05.2018, p. 935-944.

Research output: Contribution to journalArticle

Rajan, Kumar ; Barnes, Lisa L. ; Wilson, Robert S. ; Weuve, Jennifer ; McAninch, Elizabeth A. ; Evans, Denis A. / Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele. In: Annals of Neurology. 2018 ; Vol. 83, No. 5. pp. 935-944.
@article{e9dba078e3b44309badf26845f2e19ea,
title = "Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele",
abstract = "Objective: To examine the association of blood pressure (BP) with incident Alzheimer's disease (AD) dementia. Methods: This work is based on a longitudinal, cohort study of 18 years, the Chicago Health and Aging Project (CHAP) performed in 2,137 participants (55{\%} black) with systolic BP measured around 8.1 years before incident AD dementia. Results: The association of BP with risk of AD dementia was U-shaped, with the lowest risks of AD dementia near the center of the systolic BP (SBP) and diastolic BP (DBP) distributions, and modestly elevated risk at lower BPs, and greater risk at higher BPs. The degree of U-shape and the range of lowest risk (threshold ranges) varied with antihypertensive medication use and presence of the APOE ε4 allele. The U-shape was most prominent for the subgroup not taking antihypertensive medications and having an APOE ε4 allele. At higher BPs, those having the APOE ε4 allele and not receiving antihypertensive medication were at greater risk of AD dementia than other groups: The risk of incident AD dementia increased by 100{\%} (relative risk [RR] = 2.00; 95{\%} confidence interval [CI] = 1.70, 2.31) for every 10 mm Hg increase in SBP above 140 mm Hg. For DBP, the risk of incident of AD dementia increased by 57{\%} (RR = 1.57; 95{\%} CI = 1.33, 1.86) for every 5 mm Hg increase in DBP above 76 mm Hg. Interpretation: The BP risk of AD dementia association is U-shaped, with elevated risk at lower and higher BPs. People having the APOE ε4 allele and not receiving antihypertensive medication with higher BPs have notably elevated risk of AD dementia. Ann Neurol 2018;83:935–944.",
author = "Kumar Rajan and Barnes, {Lisa L.} and Wilson, {Robert S.} and Jennifer Weuve and McAninch, {Elizabeth A.} and Evans, {Denis A.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1002/ana.25228",
language = "English (US)",
volume = "83",
pages = "935--944",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Blood pressure and risk of incident Alzheimer's disease dementia by antihypertensive medications and APOE ε4 allele

AU - Rajan, Kumar

AU - Barnes, Lisa L.

AU - Wilson, Robert S.

AU - Weuve, Jennifer

AU - McAninch, Elizabeth A.

AU - Evans, Denis A.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Objective: To examine the association of blood pressure (BP) with incident Alzheimer's disease (AD) dementia. Methods: This work is based on a longitudinal, cohort study of 18 years, the Chicago Health and Aging Project (CHAP) performed in 2,137 participants (55% black) with systolic BP measured around 8.1 years before incident AD dementia. Results: The association of BP with risk of AD dementia was U-shaped, with the lowest risks of AD dementia near the center of the systolic BP (SBP) and diastolic BP (DBP) distributions, and modestly elevated risk at lower BPs, and greater risk at higher BPs. The degree of U-shape and the range of lowest risk (threshold ranges) varied with antihypertensive medication use and presence of the APOE ε4 allele. The U-shape was most prominent for the subgroup not taking antihypertensive medications and having an APOE ε4 allele. At higher BPs, those having the APOE ε4 allele and not receiving antihypertensive medication were at greater risk of AD dementia than other groups: The risk of incident AD dementia increased by 100% (relative risk [RR] = 2.00; 95% confidence interval [CI] = 1.70, 2.31) for every 10 mm Hg increase in SBP above 140 mm Hg. For DBP, the risk of incident of AD dementia increased by 57% (RR = 1.57; 95% CI = 1.33, 1.86) for every 5 mm Hg increase in DBP above 76 mm Hg. Interpretation: The BP risk of AD dementia association is U-shaped, with elevated risk at lower and higher BPs. People having the APOE ε4 allele and not receiving antihypertensive medication with higher BPs have notably elevated risk of AD dementia. Ann Neurol 2018;83:935–944.

AB - Objective: To examine the association of blood pressure (BP) with incident Alzheimer's disease (AD) dementia. Methods: This work is based on a longitudinal, cohort study of 18 years, the Chicago Health and Aging Project (CHAP) performed in 2,137 participants (55% black) with systolic BP measured around 8.1 years before incident AD dementia. Results: The association of BP with risk of AD dementia was U-shaped, with the lowest risks of AD dementia near the center of the systolic BP (SBP) and diastolic BP (DBP) distributions, and modestly elevated risk at lower BPs, and greater risk at higher BPs. The degree of U-shape and the range of lowest risk (threshold ranges) varied with antihypertensive medication use and presence of the APOE ε4 allele. The U-shape was most prominent for the subgroup not taking antihypertensive medications and having an APOE ε4 allele. At higher BPs, those having the APOE ε4 allele and not receiving antihypertensive medication were at greater risk of AD dementia than other groups: The risk of incident AD dementia increased by 100% (relative risk [RR] = 2.00; 95% confidence interval [CI] = 1.70, 2.31) for every 10 mm Hg increase in SBP above 140 mm Hg. For DBP, the risk of incident of AD dementia increased by 57% (RR = 1.57; 95% CI = 1.33, 1.86) for every 5 mm Hg increase in DBP above 76 mm Hg. Interpretation: The BP risk of AD dementia association is U-shaped, with elevated risk at lower and higher BPs. People having the APOE ε4 allele and not receiving antihypertensive medication with higher BPs have notably elevated risk of AD dementia. Ann Neurol 2018;83:935–944.

UR - http://www.scopus.com/inward/record.url?scp=85049016106&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049016106&partnerID=8YFLogxK

U2 - 10.1002/ana.25228

DO - 10.1002/ana.25228

M3 - Article

VL - 83

SP - 935

EP - 944

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 5

ER -